Brief: Paion's Chinese Remimazolam Licensee Launches Ruima In Procedural Sedation In China
11/08/2020 09:17
Aug 11 (Reuters) - PAION AG PA8G.DE :
* CO'S CHINESE REMIMAZOLAM LICENSEE YICHANG HUMANWELL HAS
RECENTLY
LAUNCHED RUIMA^(R) (REMIMAZOLAM) IN PROCEDURAL SEDATION IN CHINA
Source text for Eikon: ID:nEQ1Qn6RKa
Further company coverage: PA8G.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on PAION AG
See all newsBrief: Paion AG To Issue Approx 4.8 Mln Shares In Capital Increase With Subscription Rights
Brief: Paion AG Reports Developments On Commercial Activities In Europe
Brief: Paion Q1 EBITDA Up At EUR 15 Mln
Brief: Paion Grants Exclusive License To Cristália For Development And Commercialization Of Remimazolam In Latin America
Brief: Paion Announces Sebastian Werner As New CFO, Effective 1 June 2022